相关实验视频

Updated: May 3, 2026

Operating Transverse Aortic Constriction with Absorbable Suture to Obtain Transient Myocardial Hypertrophy

Operating Transverse Aortic Constriction with Absorbable Suture to Obtain Transient Myocardial Hypertrophy

Published on: September 9, 2020

完全内镜同时进行的大动脉和中心门手术在结节表皮溶解:一个病例报告

Kazufumi Yoshida¹, Soshi Yoshida², Yoshimasa Hori²

¹Department of Cardiovascular Surgery, Kobe City Medical Center General Hospital, 2-1-1 Minatojimaminamimachi, Chuo-ku, Kobe, 650-0047, Japan. kazu.kumfc@kcho.jp.

Journal of cardiothoracic surgery

|February 20, 2024

概括

结节性表皮溶解 (JEB) 的患者的心脏手术由于皮肤脆弱而具有挑战性. 这项研究表明,在适当保护皮肤的JEB患者中,微创门手术是安全有效的.

科学领域:

心脏病学心脏病学
皮肤病学皮肤病学
手术创新在外科创新.

背景情况:

结节性表皮溶解 (JEB) 是一种罕见的遗传疾病,导致极端的皮肤和粘膜脆弱性.
由于与皮肤创伤相关的高风险,JEB患者的心脏手术在历史上没有得到解决.
患有JEB的患者经常出现需要多学科管理的皮肤外表现.

研究的目的:

报告一个患有结节性表皮溶解的患者复杂的膜心脏病的成功手术治疗.
评估JEB患者微创心脏手术的安全性和可行性.
为JEB患者在心脏手术期间强调关键的皮肤保护策略.

主要方法:

一名55岁的男性患有先天性JEB,高血压和血管性心痛,接受了完全内镜同时进行的 mitra 门修复和大动脉门置换.
由于手术区域的皮肤相对健康,因此选择了右胸切除方法.
专用带 (聚氨和泡) 用于保护皮肤免受设备接触;用于伤口关闭,使用垂直床.

主要成果:

患者很好地忍受了完全内镜式的门手术,术后过程没有任何事件.
手术后9天发生放出,在3年后续观察时不需要重新手术.
佩尔斯维尔TM无生物假体门使该程序变得更加容易.

结论:

在JEB患者中,完全内镜的大动脉和 mitra 门手术是可行的和安全的.
细致的皮肤和粘膜保护对于接受心脏手术的JEB患者的成功结果至关重要.
这种方法为JEB患者提供了可行的选择,这些患者有显著的膜心脏病.

关键词:

大动脉门的更换服装泡是用来装饰的在内镜检查中,内镜检查皮肤溶解牛皮的牛皮质.结节性表皮溶解 (bullosa) 是一种最小的侵入性心脏手术.中心门维修 - - 中心门维修皮肤保护皮肤保护没有接的门.

更多相关视频

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Cox-Maze IV Procedure Concomitant with Valvular Surgery In Situs Inversus Dextrocardia: A Single-Center Experience in China

Published on: February 11, 2022

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Fully Endoscopic Mitral Valve Repair with Percutaneous Cannulation of Groin Vessels

Published on: May 26, 2023

相关概念视频

Mitral Valve Prolapse II: Assessment and Management

Mitral Valve Prolapse II: Assessment and Management

IntroductionA range of clinical features characterizes Mitral Valve Prolapse (MVP), but it is important to note that many individuals with MVP are asymptomatic and may remain so throughout their lives. For those who do exhibit symptoms, the following are the key clinical features:Palpitations: This is a common symptom where individuals feel an irregular or rapid heartbeat. Palpitations in MVP are often due to arrhythmias such as premature ventricular contractions or supraventricular...

Mitral Stenosis I: Introduction

Mitral Stenosis I: Introduction

Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...

Mitral Stenosis III: Medical Management

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...